BankPlus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42M Buy
1,225
+17
+1% +$20.1K 0.62% 27
2026
Q2
$1.45M Buy
1,208
+18
+2% +$18.4K 0.65% 27
2026
Q1
$1.1M Buy
1,190
+160
+16% +$162K 0.57% 29
2025
Q4
$1.11M Sell
1,030
-22
-2% -$21K 0.61% 26
2025
Q3
$803K Buy
1,052
+46
+5% +$34.2K 0.47% 35
2025
Q2
$784K Buy
1,006
+25
+3% +$19.4K 0.52% 33
2025
Q1
$810K Sell
981
-6
-0.6% -$4.99K 0.59% 30
2024
Q4
$761K Buy
+987
New +$817K 0.57% 32

Other funds holding LLY

BankPlus Wealth Management's LLY Position: Q3 2026 in Review

BankPlus Wealth Management increased its Eli Lilly (LLY) stake by 1.4% in Q3 2026, buying an estimated $20.1K and bringing the position to 1,225 shares worth $1.42M. The position accounts for 0.62% of the portfolio, ranked #27.

BankPlus Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.45M in Q2 2026. 2,957 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BankPlus Wealth Management held 1,225 shares of Eli Lilly worth $1.42M as of Q3 2026.
  • BankPlus Wealth Management bought 17 Eli Lilly shares in Q3 2026, an estimated $20.1K.
  • Eli Lilly made up 0.62% of BankPlus Wealth Management's portfolio in Q3 2026, its #27 holding.
  • BankPlus Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • BankPlus Wealth Management's Eli Lilly position peaked at $1.45M in Q2 2026.
  • 2,957 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.